| 臺大學術典藏 |
2022-09-06T08:50:56Z |
Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study
|
Huang, Sung-Hsi; Lee, Chun-Yuan; Tsai, Chin-Shiang; Tsai, Mao-Song; Liu, Chun-Eng; Hsu, Wei-Ting; Chen, Hong-An; Liu, Wang-Da; Yang, Chia-Jui; Sun, Hsin-Yun; Ko, Wen-Chien; Lu, Po-Liang; Lee, Yuan-Ti; Hung, Chien-Ching; Sun, Hsin-Yun; Huang, Yu-Shan; SUI-YUAN CHANG; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-12-02T05:41:28Z |
Ongoing transmission of Entamoeba histolytica among newly diagnosed people living with HIV in Taiwan, 2009-2018
|
Huang S.-H.; Tsai M.-S.; Lee C.-Y.; Tsai C.-S.; Liu C.-E.; Lee Y.-T.; Chen H.-A.; Chen L.-Y.; Lu Y.-M.; Tsai W.-C.; Hsu W.-T.; WANG-DA LIU; Yang C.-J.; Sun H.-Y.; Ko W.-C.; Lu P.-L.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:54Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:47Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-27T06:48:46Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:13Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
KUAN-YIN LIN; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:03Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; KUAN-YIN LIN; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-25T01:53:02Z |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Lee Y.-L.; KUAN-YIN LIN; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:35Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:28Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Lin J.-J.; Lin K.-Y.; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; YU-SHAN HUANG; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J.; Lee Y.-T.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-24T08:23:27Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
YU-SHAN HUANG; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Sun H.-Y.; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-08-20T07:10:55Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
Huang Y.-S.; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; HSIN-YUN SUN; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; Hung C.-C.; Taiwan HIV Study Group |
| 中山醫學大學 |
2021-07-18 |
Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV
|
Yu-Lin Lee; Kuan-Yin Lin; Shu-Hsing Cheng; Po-Liang Lu; Ning-Chi Wang; Mao-Wang Ho; Chia-Jui Yang; Bo-Huang Liou; Hung-Jen Tang; Shie-Shian Huang; Sung-Hsi Huang; Tun-Chieh Chen; Chi-Ying Lin; Shih-Ping Lin ; Yuan-Ti Lee; Chien-Ching Hung; Taiwan HIV Study Group |
| 臺大學術典藏 |
2021-05-06T01:25:11Z |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
Huang Y.-S.; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Sun H.-Y.; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; CHIEN-CHING HUNG; Taiwan HIV Study Group |
| 臺大學術典藏 |
2020-12-29T05:33:47Z |
Ongoing transmission of Entamoeba histolytica among newly diagnosed people living with HIV in Taiwan, 2009-2018
|
Liu W.-D.; Hsu W.-T.; Lu Y.-M.; Tsai W.-C.; Chen L.-Y.; Chen H.-A.; Lee Y.-T.; Huang S.-H.; Tsai M.-S.; Lee C.-Y.; Tsai C.-S.; Liu C.-E.; Yang C.-J.; HSIN-YUN SUN; Ko W.-C.; Lu P.-L.; Hung C.-C.; Taiwan HIV Study Group |
| 臺大學術典藏 |
2020-09-30T03:22:28Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Zhang J.-Y.; Sun H.-Y.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; Huang Y.-S.; Tsai M.-S.; Lee Y.-L.; Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; CHIEN-CHING HUNG; Taiwan HIV Study Group |
| 臺大學術典藏 |
2020-09-30T03:22:28Z |
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up
|
Lin S.-P.; Lee Y.-C.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Li C.-W.; Lin K.-Y.; Cheng C.-Y.; Huang Y.-S.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG; Taiwan HIV Study Group |
| 臺大學術典藏 |
2020-09-30T03:22:21Z |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan
|
Taiwan HIV Study Group; CHIEN-CHING HUNG; Lee Y.-T.; Lin J.-J.; Lin K.-Y.; Tang H.-J.; Lin S.-P.; Lee Y.-C.; Liu C.-E.; Huang Y.-S.; Wang N.-C.; Li C.-W.; Ko W.-C.; Yang H.-J. |
| 臺大學術典藏 |
2020-09-30T03:22:13Z |
Ongoing transmission of Entamoeba histolytica among newly diagnosed people living with HIV in Taiwan, 2009-2018
|
Huang S.-H.;Tsai M.-S.;Lee C.-Y.;Tsai C.-S.;Liu C.-E.;Lee Y.-T.;Chen H.-A.;Chen L.-Y.;Lu Y.-M.;Tsai W.-C.;Hsu W.-T.;Liu W.-D.;Yang C.-J.;Sun H.-Y.;Ko W.-C.;Lu P.-L.;Chien-Ching Hung;Taiwan Hiv Study Group; Huang S.-H.; Tsai M.-S.; Lee C.-Y.; Tsai C.-S.; Liu C.-E.; Lee Y.-T.; Chen H.-A.; Chen L.-Y.; Lu Y.-M.; Tsai W.-C.; Hsu W.-T.; Liu W.-D.; Yang C.-J.; Sun H.-Y.; Ko W.-C.; Lu P.-L.; CHIEN-CHING HUNG; Taiwan HIV Study Group |
| 臺大學術典藏 |
2020-09-30T03:22:12Z |
Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV
|
Chen G.-J.; Lee Y.-L.; Lee C.-H.; Sun H.-Y.; Cheng C.-Y.; Tsai H.-C.; Huang S.-H.; Lee Y.-C.; Hsieh M.-H.; Chang S.-Y.; Chuang Y.-C.; Su L.-S.; Chang S.-F.; Tang H.-J.; CHIEN-CHING HUNG; Taiwan HIV Study Group; Chen G.-J.;Lee Y.-L.;Lee C.-H.;Sun H.-Y.;Cheng C.-Y.;Tsai H.-C.;Huang S.-H.;Lee Y.-C.;Hsieh M.-H.;Chang S.-Y.;Chuang Y.-C.;Su L.-S.;Chang S.-F.;Tang H.-J.;Chien-Ching Hung;Taiwan Hiv Study Group |
| 中山醫學大學 |
2020-06-20 |
Ongoing transmission of Entamoeba histolytica among newly diagnosed people living with HIV in Taiwan, 2009-2018
|
Sung-Hsi Huang; Mao-Song Tsai; Chun-Yuan Lee; Chin-Shiang Tsai;Chun-Eng Liu;Yuan-Ti Lee;Hong-An Chen;Ling-Ya Chen;Yu-Man Lu;Wan-Chen Tsai;Wei-Ting Hsu;Wang-Da Liu;Chia-Jui Yang;Taiwan HIV Study Group |
| 中山醫學大學 |
2019-07-01 |
Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia
|
Yu-Shan Huang; Chun-Eng Liu; Shih-Ping Lin; Chen-Hsiang Lee; Chia-Jui Yang; Chi-Ying Lin; Hung-Jen Tang; Yi-Chien Lee; Yi-Chun Lin; Yuan-Ti Lee; Hsin-Yun Sun; Chien-Ching Hung; Taiwan HIV Study Group |
